Skip to content

Comparing the efficacy of intravenous Dexamethasone and Inhaler N-Acetyl Cysteine plus intravenous Dexamethasone in treatment of Respiratory Distress Syndrome

Comparing the efficacy of intravenous Dexamethasone and N-Acetyl Cysteine nebulizer plus intravenous Dexamethasone in treatment of Respiratory Distress Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101917413N21
Enrollment
60
Registered
2016-11-03
Start date
2015-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: ?First group will undergo treatment with Intravenous Dexamethasone 0.15 mg/kg every 12 hours for 3 to 5 days. Intervention 2: The second group will undergo treatment with inhaler N-Ace
Treatment - Drugs
The second group will undergo treatment with inhaler N-Acetyl Cysteine through jet nebulizer (400 mg every 8 hours) for 3 to 5 days.

Sponsors

Vice chancellor for research, Pharmaceutical Sciences Branch, Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 1 Months

Inclusion criteria

Inclusion criteria: Inclusion criteria: birth weight between 1000-2500 gr;Gestational age of less than 36 weeks;Mechanical ventilation for at least two days;Oxygen saturation of more than 30% after extubation;PH55;PaO2<50 Exclusion Criteria:Hemorrhagic lesions;Congenital Anomalies;Chromosomal Anomalies;early sepsis;death before 72 hours of age

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Respiratory rate. Timepoint: before and after extubation. Method of measurement: one minute counting by nurse.;PH. Timepoint: before and after extubation. Method of measurement: Arterial Blood Gas Assessment.;Blood Pressure. Timepoint: before and after extubation. Method of measurement: Monitring System.;Oxygen Saturation. Timepoint: before and after extubation. Method of measurement: Pulse Oxymetry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Khosravi

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

dr.mhkhosravi@gmail.com+98 21 8862 0826

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026